Latest filing published 22 Sept 2015 for Insys Therapeutics, Inc., €23k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael L. Babich: trading record in brief
This profile gathers the share dealings of Michael L. Babich in Insys Therapeutics, Inc. We count 44 filings; the first trade dates from 7 May 2013 and the latest from 22 September 2015.
The open-market side counts 2 purchases for €29k alongside 23 sales for €22.9M. Taken together, the sales exceed the purchases by €22.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 18 option exercises. 2015 to date brings no purchases and 7 sales.
On 22 September 2015 came the latest disclosure, an option exercise for €23k in Insys Therapeutics, Inc. The last insider purchase was made public on 16 August 2013, 4,833 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael L. Babich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,068 shares@ US$1.62Common StockSEC:0001209191-15-071908:0
- 5,000 shares@ US$3.25Common StockSEC:0001209191-15-028226:0
- 30,000 shares@ US$3.25Common StockSEC:0001209191-15-027512:0
- 45,755 shares@ US$2.36Common StockSEC:0001209191-15-027512:1
- 1,845 shares@ US$7.26Common StockSEC:0001209191-15-027512:2
- 8,224 shares@ US$57.91Common StockSEC:0001209191-15-027512:3
- 23,500 shares@ US$59.07Common StockSEC:0001209191-15-027512:4
- 13,546 shares@ US$59.71Common StockSEC:0001209191-15-027512:5
- 2,330 shares@ US$60.62Common StockSEC:0001209191-15-027512:6
- 27,400 shares@ US$7.26Common StockSEC:0001209191-15-027512:7
- 12,500 shares@ US$57.21Common StockSEC:0001209191-15-027512:8
- 13,300 shares@ US$58.12Common StockSEC:0001209191-15-027512:9
- 1,600 shares@ US$58.95Common StockSEC:0001209191-15-027512:10
- 2,500 shares@ US$3.25Common StockSEC:0001209191-14-077436:0
- 20,000 shares@ US$2.36Common StockSEC:0001209191-14-066347:0
- 72,500 shares@ US$2.36Common StockSEC:0001209191-14-066392:0
- 17,922 shares@ US$37.58Common StockSEC:0001209191-14-066392:1
- 30,197 shares@ US$38.57Common StockSEC:0001209191-14-066392:2
- 13,661 shares@ US$39.66Common StockSEC:0001209191-14-066392:3
- 10,720 shares@ US$40.41Common StockSEC:0001209191-14-066392:4
- 7,500 shares@ US$2.36Common StockSEC:0001209191-14-066392:5
- 7,500 shares@ US$37.27Common StockSEC:0001209191-14-066392:6
- 20,000 shares@ US$3.54Common StockSEC:0001209191-14-064327:0
- 20,000 shares@ US$40.17Common StockSEC:0001209191-14-064327:1
- 5,000 shares@ US$3.25Common StockSEC:0001209191-14-063547:0
25 of 44 declarations
